SCN9A and hereditary sensory and autonomic neuropathy: SCN9A mutations have been associated with various pain disorders, including gain-of-function paroxysmal extreme pain disorder (PEPD) and the loss-of-function disorder congenital insensitivity to pain (CIP) (21–23).